The levels of β2-GM, TNF-α, IFN-γ, M-CSF, TGF, and VEGF related to immunity or inflammation improved to near normal (P > 0.05), as shown in Figure 11C. All the results demonstrated that HEP3 had a strong inhibitory activity and could be used for the treatment of tumor as a FIP. The gene discussed is TNF; the disease is neoplasm.